Clinical Trial Update: NLR and PLR Levels Following PENG Block in Hip Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) after a PENG block in hip arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Arthropathy
• Hip Osteoarthritis

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Hip Arthropathy, Hip Osteoarthritis | Phase 4 | Status: COMPLETED